# Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

> **NCT01269606** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 13 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** insulin human
- **DRUG:** insulin aspart
- **DRUG:** insulin human

## Key facts

- **NCT ID:** NCT01269606
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269606, "Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01269606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*